tirzepatide injection needle Diabetes drug resolves sleep apnea in up to 52% of patients—is FDA approval in the cards? Mounjaro (Tirzepatide) is a type of medication called a dual glucose Zepbound® for Weight Loss: Same-day

March 2026: By March 2026, reports described the GLP-1 MDL as still growing rapidly, with more than 3,300 cases pending in federal court

Depending on your response and tolerance, your healthcare provider may increase your dose gradually

While the most common side effects are gastrointestinal such as nausea, vomiting, and diarrhea serious complications like pancreatitis are much less frequent

physically, those sensations come from transient changes in how the heart contracts or how blood is pumped

At last years American Diabetes Associations (ADA) 83rd Scientific Sessions in San Diego, LLY reported that retatrutide had been shown, in a phase 2 trial, to reduce liver fat by over 80%

In the head-to-head SURMOUNT-5 trial, Zepbound resulted in an average total body weight loss of 20.2%, compared to 13.7% for Wegovy